|
HADHB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.973400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.120400E-01 |
| Normal-vs-Stage2 |
5.297300E-03 |
| Normal-vs-Stage3 |
9.944500E-02 |
| Normal-vs-Stage4 |
5.158200E-01 |
| Stage1-vs-Stage2 |
2.879300E-03 |
| Stage1-vs-Stage3 |
2.720200E-01 |
| Stage1-vs-Stage4 |
7.331000E-01 |
| Stage2-vs-Stage3 |
9.834900E-04 |
| Stage2-vs-Stage4 |
4.479100E-03 |
| Stage3-vs-Stage4 |
7.427000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.893220E-01 |
| Normal-vs-AfricanAmerican |
9.407000E-01 |
| Normal-vs-Asian |
5.053800E-01 |
| Caucasian-vs-AfricanAmerican |
6.225400E-01 |
| Caucasian-vs-Asian |
2.372600E-01 |
| AfricanAmerican-vs-Asian |
5.483400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.020800E-01 |
| Normal-vs-Female |
8.380400E-01 |
| Male-vs-Female |
5.801600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.452800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.546200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.478400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.616040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.079800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.319770E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.865000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.658400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.986600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.097600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.796800E-01 |
| Classical-VS-Follicular |
7.13749999992075E-07 |
| Classical-VS-Other |
9.419600E-01 |
| Classical-VS-Normal |
2.477700E-02 |
| Tall-VS-Follicular |
9.19510000030321E-07 |
| Tall-VS-Other |
9.349400E-01 |
| Tall-VS-Normal |
2.297600E-02 |
| Follicular-VS-Other |
1.173000E-01 |
| Follicular-VS-Normal |
1.037440E-04 |
| Other-VS-Normal |
6.681600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.978150E-01 |
| Normal-vs-N1 |
1.463450E-03 |
| N0-vs-N1 |
1.045820E-04 |
|
|
